GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » Net Margin %

Pharmagreen Biotech (Pharmagreen Biotech) Net Margin % : -16,300.00% (As of Jun. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Pharmagreen Biotech's Net Income for the three months ended in Jun. 2023 was $-0.16 Mil. Pharmagreen Biotech's Revenue for the three months ended in Jun. 2023 was $0.00 Mil. Therefore, Pharmagreen Biotech's net margin for the quarter that ended in Jun. 2023 was -16,300.00%.

The historical rank and industry rank for Pharmagreen Biotech's Net Margin % or its related term are showing as below:

PHBI' s Net Margin % Range Over the Past 10 Years
Min: -25000   Med: 0   Max: 0
Current: -25000


PHBI's Net Margin % is ranked worse than
99.02% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.53 vs PHBI: -25000.00

Pharmagreen Biotech Net Margin % Historical Data

The historical data trend for Pharmagreen Biotech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech Net Margin % Chart

Pharmagreen Biotech Annual Data
Trend Apr08 Apr09 Sep18 Sep19 Sep20 Sep21 Sep22
Net Margin %
Get a 7-Day Free Trial - - - - -

Pharmagreen Biotech Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -18,800.00 -16,300.00

Competitive Comparison of Pharmagreen Biotech's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmagreen Biotech's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's Net Margin % distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's Net Margin % falls into.



Pharmagreen Biotech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Pharmagreen Biotech's Net Margin for the fiscal year that ended in Sep. 2022 is calculated as

Net Margin=Net Income (A: Sep. 2022 )/Revenue (A: Sep. 2022 )
=-0.875/0
= %

Pharmagreen Biotech's Net Margin for the quarter that ended in Jun. 2023 is calculated as

Net Margin=Net Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-0.163/0.001
=-16,300.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmagreen Biotech  (OTCPK:PHBI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Pharmagreen Biotech Net Margin % Related Terms

Thank you for viewing the detailed overview of Pharmagreen Biotech's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
112 North Curry Street, Carson, NV, USA, 89703
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.